Clinical Trials

Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease

by ClinicalTrialsFeed • 2015/07/27 • 0 Comments

Status: Recruiting, Condition Summary: Dry Eye Syndromes

← VIDEO: Defining and treating astigmatism

Opternative Revolutionizes Eye Exams with Launch of Online, Ophthalmologist-Issued Prescription Service for Glasses and Contacts →